Constipation diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[Diagnostic study of choice]] for constipation is ROME III criteria. Rome III criteria includes [[symptom]] onset for more than 6 months and two or more number of specific [[symptoms]]. Specific | [[Diagnostic study of choice]] for constipation is ROME III criteria. Rome III criteria includes [[symptom]] onset for more than 6 months and two or more number of specific [[symptoms]]. Specific [[symptoms]] of constipation include straining, hard [[stool]], sensation of incomplete evacuation, sensation of [[obstruction]], necessity of manual maneuvers, less than 3 [[Bowel movement|bowel movements]] per week, lack of loose stool, and lack of [[Irritable bowel syndrome|irritable bowel syndrome (IBS)]]. | ||
==Diagnostic Study of Choice== | ==Diagnostic Study of Choice== | ||
The [[diagnostic criteria]] based on the [[American Gastroenterological Association|American Gastroenterological Association (AGA)]]<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref> | The [[diagnostic criteria]] based on the [[American Gastroenterological Association|American Gastroenterological Association (AGA)]], Rome III criteria, and pharmacologic studies based criteria are as follows:<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Longstreth-2006">{{Cite journal | last1 = Longstreth | first1 = GF. | last2 = Thompson | first2 = WG. | last3 = Chey | first3 = WD. | last4 = Houghton | first4 = LA. | last5 = Mearin | first5 = F. | last6 = Spiller | first6 = RC. | title = Functional bowel disorders. | journal = Gastroenterology | volume = 130 | issue = 5 | pages = 1480-91 | month = Apr | year = 2006 | doi = 10.1053/j.gastro.2005.11.061 | PMID = 16678561 }}</ref><ref name="Lembo-2010">{{Cite journal | last1 = Lembo | first1 = AJ. | last2 = Kurtz | first2 = CB. | last3 = Macdougall | first3 = JE. | last4 = Lavins | first4 = BJ. | last5 = Currie | first5 = MG. | last6 = Fitch | first6 = DA. | last7 = Jeglinski | first7 = BI. | last8 = Johnston | first8 = JM. | title = Efficacy of linaclotide for patients with chronic constipation. | journal = Gastroenterology | volume = 138 | issue = 3 | pages = 886-95.e1 | month = Mar | year = 2010 | doi = 10.1053/j.gastro.2009.12.050 | PMID = 20045700 }}</ref> | ||
{| | {| | ||
| style="background:#4479BA; color: #FFFFFF;" align="center" + | '''Rome III criteria'''<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Longstreth-2006">{{Cite journal | last1 = Longstreth | first1 = GF. | last2 = Thompson | first2 = WG. | last3 = Chey | first3 = WD. | last4 = Houghton | first4 = LA. | last5 = Mearin | first5 = F. | last6 = Spiller | first6 = RC. | title = Functional bowel disorders. | journal = Gastroenterology | volume = 130 | issue = 5 | pages = 1480-91 | month = Apr | year = 2006 | doi = 10.1053/j.gastro.2005.11.061 | PMID = 16678561 }}</ref> | |||
| style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Pharmacologic studies based criteria'''<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Lembo-2010">{{Cite journal | last1 = Lembo | first1 = AJ. | last2 = Kurtz | first2 = CB. | last3 = Macdougall | first3 = JE. | last4 = Lavins | first4 = BJ. | last5 = Currie | first5 = MG. | last6 = Fitch | first6 = DA. | last7 = Jeglinski | first7 = BI. | last8 = Johnston | first8 = JM. | title = Efficacy of linaclotide for patients with chronic constipation. | journal = Gastroenterology | volume = 138 | issue = 3 | pages = 886-95.e1 | month = Mar | year = 2010 | doi = 10.1053/j.gastro.2009.12.050 | PMID = 20045700 }}</ref> | |||
|- | |- | ||
| '''''Symptom onset for ≥ 6 months and ≥ 2 of the following for the past 3 months:''''' | | style="background:#F5F5F5;" + | '''''Symptom onset for ≥ 6 months and ≥ 2 of the following for the past 3 months:''''' | ||
* Straining during at least one-fourth of [[Defecation|defecations]] | * Straining during at least one-fourth of [[Defecation|defecations]] | ||
* Hard or lumpy [[stools]] in at least one-fourth of [[Defecation|defecations]] | * Hard or lumpy [[stools]] in at least one-fourth of [[Defecation|defecations]] | ||
| Line 22: | Line 23: | ||
* Without the use of [[laxatives]], loose [[stools]] are rarely present | * Without the use of [[laxatives]], loose [[stools]] are rarely present | ||
* No sufficient criteria for [[Irritable bowel syndrome|irritable bowel syndrome (IBS)]] | * No sufficient criteria for [[Irritable bowel syndrome|irritable bowel syndrome (IBS)]] | ||
|| '''''Spontaneous bowel movements < 3 per week and ≥ 1 of the following for at least 12 weeks during the past 12 months:''''' | | style="background:#F5F5F5;" + | '''''Spontaneous bowel movements < 3 per week and ≥ 1 of the following for at least 12 weeks during the past 12 months:''''' | ||
* Straining during at least one-fourth of [[Defecation|defecations]] | * Straining during at least one-fourth of [[Defecation|defecations]] | ||
* Hard or lumpy [[stools]] in at least one-fourth of [[Defecation|defecations]] | * Hard or lumpy [[stools]] in at least one-fourth of [[Defecation|defecations]] | ||
Revision as of 21:27, 8 January 2018
|
Constipation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Constipation On the Web |
|
American Roentgen Ray Society Images of Constipation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
Overview
Diagnostic study of choice for constipation is ROME III criteria. Rome III criteria includes symptom onset for more than 6 months and two or more number of specific symptoms. Specific symptoms of constipation include straining, hard stool, sensation of incomplete evacuation, sensation of obstruction, necessity of manual maneuvers, less than 3 bowel movements per week, lack of loose stool, and lack of irritable bowel syndrome (IBS).
Diagnostic Study of Choice
The diagnostic criteria based on the American Gastroenterological Association (AGA), Rome III criteria, and pharmacologic studies based criteria are as follows:[1][2][3]
| Rome III criteria[1][2] | Pharmacologic studies based criteria[1][3] |
Symptom onset for ≥ 6 months and ≥ 2 of the following for the past 3 months:
|
Spontaneous bowel movements < 3 per week and ≥ 1 of the following for at least 12 weeks during the past 12 months:
|
References
- ↑ 1.0 1.1 1.2 Bharucha AE, Pemberton JH, Locke GR (2013). "American Gastroenterological Association technical review on constipation". Gastroenterology. 144 (1): 218–38. doi:10.1053/j.gastro.2012.10.028. PMC 3531555. PMID 23261065.
- ↑ 2.0 2.1 Longstreth, GF.; Thompson, WG.; Chey, WD.; Houghton, LA.; Mearin, F.; Spiller, RC. (2006). "Functional bowel disorders". Gastroenterology. 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 Lembo, AJ.; Kurtz, CB.; Macdougall, JE.; Lavins, BJ.; Currie, MG.; Fitch, DA.; Jeglinski, BI.; Johnston, JM. (2010). "Efficacy of linaclotide for patients with chronic constipation". Gastroenterology. 138 (3): 886–95.e1. doi:10.1053/j.gastro.2009.12.050. PMID 20045700. Unknown parameter
|month=ignored (help)